Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
30.74
+0.24 (0.79%)
Mar 10, 2026, 10:15 AM CST
115.72% (1Y)
| Market Cap | 12.37B |
| Revenue (ttm) | 704.16M |
| Net Income (ttm) | 22.23M |
| Shares Out | 405.71M |
| EPS (ttm) | 0.05 |
| PE Ratio | 556.60 |
| Forward PE | 210.34 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,903,920 |
| Average Volume | 5,798,375 |
| Open | 31.00 |
| Previous Close | 30.50 |
| Day's Range | 29.80 - 31.00 |
| 52-Week Range | 12.45 - 34.68 |
| Beta | 0.51 |
| RSI | 61.03 |
| Earnings Date | Mar 20, 2026 |